fda bpc-157 category 2 bulk drug substance compounding list An advisory committee voted Thursday to remove restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8-6 votes (with THE PCCA BLOG | FDA
THE PCCA BLOG FDA Guidance Explained: Compounding with Bulk Dru BPC 157 PASSED! Gabriel Alizaidy, MD, MS I also agree with you, the FDA's data pitch was very disappointing For the compounding industry, this is a positive vote. It does not immediately make Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List Frier Levitt FDA Peptide Update 2026: Removal from Do Not Compound List and What It Means for Pharmacies FDA's Overreach on Compounded Peptides
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8


